Fresenius SE & Co KGaA (FRE) Given a €75.00 Price Target at Nord/LB

Nord/LB set a €75.00 ($87.21) target price on Fresenius SE & Co KGaA (FRA:FRE) in a research note released on Thursday morning. The brokerage currently has a buy rating on the stock.

FRE has been the topic of several other reports. Jefferies Financial Group set a €59.00 ($68.60) price target on shares of Fresenius SE & Co KGaA and gave the company a neutral rating in a report on Monday, October 1st. Cfra set a €76.00 ($88.37) price target on shares of Fresenius SE & Co KGaA and gave the company a buy rating in a report on Tuesday, October 2nd. Commerzbank set a €83.00 ($96.51) price target on shares of Fresenius SE & Co KGaA and gave the company a buy rating in a report on Tuesday, September 11th. Sanford C. Bernstein set a €83.00 ($96.51) price target on shares of Fresenius SE & Co KGaA and gave the company a buy rating in a report on Monday, October 8th. Finally, Independent Research set a €66.00 ($76.74) price target on shares of Fresenius SE & Co KGaA and gave the company a neutral rating in a report on Wednesday, October 17th. One research analyst has rated the stock with a sell rating, six have given a hold rating and fourteen have assigned a buy rating to the company’s stock. Fresenius SE & Co KGaA currently has a consensus rating of Buy and an average target price of €75.84 ($88.19).

Fresenius SE & Co KGaA stock opened at €54.84 ($63.77) on Thursday. Fresenius SE & Co KGaA has a twelve month low of €60.16 ($69.95) and a twelve month high of €80.00 ($93.02).

Fresenius SE & Co KGaA Company Profile

Fresenius SE & Co KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care worldwide. The company operates through Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed segments. The Fresenius Medical Care segment offers products for patients with chronic kidney failure.

Featured Article: Price to Earnings Ratio (PE), For Valuing Stocks

Analyst Recommendations for Fresenius SE & Co KGaA (FRA:FRE)

Receive News & Ratings for Fresenius SE & Co KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius SE & Co KGaA and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply